Print Page     Close Window     

Investor Overview

Corporate Profile

Selecta Biosciences is a clinical-stage biopharmaceutical company developing targeted immunotherapies and vaccines that are designed to modulate immune responses to treat and prevent disease. Selecta’s proprietary Synthetic Vaccine Particle (SVP™) platform has the potential to create a new paradigm in immunology and may enable a novel approach for selectively targeting the immune system to effectively and safely treat and prevent rare and serious dis... View more »

Recent News
View all press releases »
Download DocumentationMar 27, 2017
Selecta Q4 and Year End 2016 Conference Call Presentation
Upcoming Events
Apr 04, 2017 1:40 p.m. ET
Selecta Biosciences, Inc. at 16th Annual Needham Healthcare Conference
remind me days before the event
Enter your e-mail address 
View all events »
Stock Quote
NASDAQ GS :  SELB (Common Stock)
$14.05
0.00 (0.00%)
Stock chart for: SELB.O.  Currently trading at $14.05 with a 52 week high of $28.00 and a 52 week low of $10.26.
Data as of Mar 29, 2017 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
IR Contact
Jason Fredette
Selecta Biosciences
Phone: 1 617 231 8078
E-mail: JFredette@selectabio.com

Data provided by Nasdaq. Minimum 15 minutes delayed.

© Selecta Biosciences, Inc. All rights reserved.